Josh Shin |

PARTNER AT FANGDA PARTNERS
Mr. Josh Shin has about 17 years of experience in M&A, private equity investment, regulatory advisory and general corporate works, with extensive knowledge in the various industries including life science, healthcare, chemicals and private education. He was graduated from University College London and Fudan University, and was admitted in the PRC.

Mr. Shin leads the healthcare practice of the firm’s corporate group. His experience in the sector includes major transactions in the sub-areas of pharmaceuticals, medical devices and medical services, as well as routinely offering advice to clients on regulatory developments in issues at the forefront of this area of law. Josh is regularly called on to offer comprehensive legal advices to MNCs and biotech start-ups on issues arising from daily operations to cover pipeline induction, clinical development, HGR administration, commercialization, patient programs, interaction with interest groups, etc., and was commissioned de facto general counsel roles in certain companies to oversee their legal establishment. He was mentioned as leading lawyer for healthcare by Chambers and Partners – Asia Pacific 2019 through 2021, and as leading individual for life sciences by Legal 500 2020 & 2021.